Welcome to our dedicated page for Miivo Holdings news (Ticker: MIVOF), a resource for investors and traders seeking the latest updates and insights on Miivo Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Miivo Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Miivo Holdings's position in the market.
Miivo (OTC: MIVOF) announced the appointment of Brady Rak to its Board of Directors effective October 21, 2025, replacing Virginia Olnick and subject to TSX Venture Exchange approval. Rak brings over 15 years of Canadian capital markets and business development experience and currently serves as VP Business Development at Skyharbour Resources.
The company also granted a total of 1,215,000 incentive stock options and 1,095,000 restricted share rights to directors, officers, advisors and consultants, subject to Exchange acceptance. Options vest one-third at grant and in two six-month installments, expire in 5 years and have an exercise price of $0.40. RSRs convert to common shares on the one-year anniversary. Issued shares are subject to a hold period until February 22, 2026.
FAQ
What is the current stock price of Miivo Holdings (MIVOF)?
